|
1
|
Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol.
|
N Engl J Med
|
2004
|
3.49
|
|
2
|
Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion.
|
Arterioscler Thromb Vasc Biol
|
2005
|
1.43
|
|
3
|
Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans.
|
Arterioscler Thromb Vasc Biol
|
2006
|
1.13
|
|
4
|
Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism.
|
J Lipid Res
|
2007
|
0.86
|
|
5
|
Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism.
|
J Lipid Res
|
2009
|
0.82
|
|
6
|
Evaluation of methods for improving precision of blood pressure measurements in phase I clinical trials.
|
J Clin Pharmacol
|
2004
|
0.78
|